2015
DOI: 10.1016/j.cellsig.2015.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological targeting of AKAP-directed compartmentalized cAMP signalling

Abstract: The second messenger cyclic adenosine monophosphate (cAMP) can bind and activate protein kinase A (PKA). The cAMP/PKA system is ubiquitous and involved in a wide array of biological processes and therefore requires tight spatial and temporal regulation. Important components of the safeguard system are the A-kinase anchoring proteins (AKAPs), a heterogeneous family of scaffolding proteins defined by its ability to directly bind PKA. AKAPs tether PKA to specific subcellular compartments, and they bind further in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
67
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 67 publications
(67 citation statements)
references
References 261 publications
0
67
0
Order By: Relevance
“…Although all AKAPs are provided from a specific structural motif for binding the regulatory subunit of PKA, they have been implicated in a variety of cellular functions that do not necessarily depend on PKA. Whereas the elucidation of their mechanisms responsible for their pleiotropic functions will require further work, AKAPs are already targets of pharmacological intervention in immunodeficiency disorders, such as AIDS [163,164]. Hence, their functional characterization in T cells, which are major players in these diseases, has become a priority.…”
Section: Effector Pathways-pka and Epac1mentioning
confidence: 99%
“…Although all AKAPs are provided from a specific structural motif for binding the regulatory subunit of PKA, they have been implicated in a variety of cellular functions that do not necessarily depend on PKA. Whereas the elucidation of their mechanisms responsible for their pleiotropic functions will require further work, AKAPs are already targets of pharmacological intervention in immunodeficiency disorders, such as AIDS [163,164]. Hence, their functional characterization in T cells, which are major players in these diseases, has become a priority.…”
Section: Effector Pathways-pka and Epac1mentioning
confidence: 99%
“…A-kinase anchoring proteins (AKAPs) 2 directly interact with the regulatory (R) subunits of PKA and facilitate PKA phosphorylation of its substrates at specific intracellular compartments (3)(4)(5). This coordinating function of AKAPs is not limited to PKA signaling; AKAPs directly bind further signaling proteins and thereby coordinate crosstalk between multiple signaling pathways.…”
mentioning
confidence: 99%
“…These anchor points may generally influence the binding affinity between AKAPs and R subunits of PKA, and may thus also lead to new strategies for pharmacological targeting of other AKAP–PKA interactions. This is so far not possible because only global disruptors of AKAP–PKA interactions are available [4]. …”
Section: Discussionmentioning
confidence: 99%
“…Peptides derived from AKBs of AKAPs such as AKAP-Lbc (peptide Ht31) or AKAP18 δ (peptide AKAP18 δ L314E) bind regulatory subunits of PKA with nanomolar affinity, and thereby globally uncouple PKA from AKAPs [4,34,35]. More recent studies led to peptides that preferentially disrupt AKAP–RI or AKAP–RII interactions [36–41].…”
Section: Introductionmentioning
confidence: 99%